查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1788282

全球病患控制镇痛帮浦市场

Patient-Controlled Analgesic Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球病患控制止痛帮浦市场规模将达到 6.869 亿美元

全球患者自控疼痛帮浦市场规模预计在2024年达到5.059亿美元，预计2024年至2030年期间的复合年增长率为5.2%，到2030年将达到6.869亿美元。本报告分析的细分市场之一－电子市场，预期复合年增长率为4.5%，到分析期间结束时市场规模将达到4.556亿美元。机械市场在分析期间的复合年增长率预计为6.9%。

美国市场规模估计为 1.33 亿美元，中国市场预计复合年增长率为 5.1%

美国患者自控止痛帮浦市场规模预计2024年达到1.33亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.104亿美元，在2024-2030年的分析期间内，复合年增长率为5.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.5%和4.6%。在欧洲，德国市场的复合年增长率预计为4.3%。

全球病患控制镇痛帮浦市场—主要趋势与驱动因素摘要

疼痛管理的新时代？患者自控式镇痛帮浦的应用日益普及

疼痛管理已成为现代医疗保健的重点，而患者自控镇痛 (PCA) 帮浦正在彻底改变疼痛缓解的给药方式。 PCA 帮浦可让患者透过静脉、硬膜外或皮下注射自行管理止痛药物，例如鸦片类药物和局部麻醉剂。 PCA 帮浦广泛应用于术后復健、癌痛管理和安宁疗护，可提供个人化的疼痛缓解，同时减少对护理人员的依赖。与传统的疼痛管理方法不同，PCA 帮浦能够在预先设定的安全限度内按需给药，从而最大限度地降低过量用药和副作用的风险。慢性疼痛盛行率的不断上升、手术量的不断增加以及先进的疼痛管理通讯协定，正在推动医院、门诊手术中心和家庭护理机构对 PCA 泵的需求。随着全球阿片类药物危机引发人们对处方药滥用的担忧，PCA 技术正在不断改进，以纳入剂量限制功能、智慧药物监测和电子健康记录(EHR) 集成，以确保安全有效的疼痛管理。随着医疗保健提供者优先考虑以患者为中心的方法，PCA 帮浦正在成为增强疼痛管理和提高患者满意度的首选解决方案。

智慧技术如何为PCA帮浦提供动力：人工智慧、无线监控和药物安全创新

智慧技术的整合正在改变 PCA 泵，使其更安全、更有效率，并更好地融入现代医疗保健系统。先进的 PCA 帮浦现配备无线连接功能，可让医疗保健提供者进行即时远端监控，防止发生过量用药事件，并确保最佳的疼痛管理。 PCA 设备中正在内建人工智慧演算法，以分析患者反应，检测阿片类药物引起的呼吸抑制的早期迹象，并相应地调整给药参数。闭合迴路给药系统和条码药物验证等药物输送创新进一步提高了 PCA 帮浦的准确性，减少了用药错误，并确保遵守医院安全通讯协定。具有输液分析功能的智慧 PCA 帮浦可以追踪患者的使用模式，并提供预测性见解以优化疼痛管理。与医院 EHR 的整合可以实现药物管理的自动记录，提高临床工作流程效率和法规遵循。非侵入性 PCA 技术的发展，包括经皮和鼻腔给药系统，也因向患者提供无针止痛选择而越来越受欢迎。随着数位健康生态系统的发展，人工智慧、数据分析和连网型设备的融合正在重塑 PCA 泵格局，使疼痛管理更安全、更有效。

PCA泵浦在哪些领域使用？医疗保健领域应用日益广泛

PCA帮浦正成为医院、门诊外科中心、安宁疗护和居家医疗保健机构疼痛管理的重要组成部分。在医院，PCA帮浦广泛应用于术后恢復室，用于管理大型手术（包括整形外科、心血管和腹部手术）后的急性疼痛。癌症治疗中心利用PCA技术帮助患者控制严重的癌症相关疼痛，并确保在化疗和安宁疗护期间持续缓解疼痛。家庭医疗保健机构越来越多地部署可携式PCA泵，使慢性疼痛患者能够在家中控制疼痛。门诊手术中心正在将PCA设备整合到当日手术护理方案中，以实现有效的疼痛缓解并缩短恢復时间。 PCA帮浦也被用于儿科和老年病科，其特殊的安全功能旨在最大限度地降低弱势患者群体的风险。军队和创伤部门正在探索将PCA技术用于战场伤病管理，为偏远地区的受伤士兵提供快速的疼痛缓解。随着医疗机构不断采用先进的疼痛管理解决方案，各种医疗机构对PCA帮浦的需求都在成长。

患者控制疼痛泵市场的成长受到多种因素的推动…

全球外科手术发生率的上升是推动PCA泵市场成长的主要因素。癌症、关节炎和神经病变疼痛等慢性疼痛疾病的日益流行，推动了对先进疼痛管理解决方案的需求。以病人为中心的照护模式的转变，推动了医疗保健提供者对PCA帮浦的采用，使病人在疼痛管理方面拥有更大的自主权。人工智慧监控、无线连接和自动化给药控制等技术进步，使PCA帮浦更安全、更有效率。人们对阿片类药物滥用和过量摄取的担忧日益加剧，这促使人们开发出具有增强用药安全功能的智慧PCA帮浦。家庭医疗保健和远端患者监护的扩展，为携带式和可穿戴PCA设备创造了新的机会。促进安全疼痛管理实践和阿片类药物管理计划的监管要求，正在推动医院和医疗机构采用PCA泵。对数位医疗基础设施的持续投资，促进了PCA泵与医院电子健康记录(EHR) 和临床决策支援系统的无缝整合。医疗设备和製药公司之间的策略联盟正在推动疼痛缓解技术的创新。随着医疗保健系统不断向精准医疗和数据主导的疼痛管理策略发展，患者控制疼痛帮浦市场有望持续成长，并将改变疼痛治疗的未来。

部分

类型（电子、机械）、应用（糖尿病、肿瘤学、胃肠病学、血液学、其他）、最终用途（医院、专科诊所、门诊手术中心、居家医疗机构）

受访公司范例

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company（BD）
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc.（Hospira）
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical（ICU Medical）
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP32496

Global Patient-Controlled Analgesic Pumps Market to Reach US$686.9 Million by 2030

The global market for Patient-Controlled Analgesic Pumps estimated at US$505.9 Million in the year 2024, is expected to reach US$686.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Electronic, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$455.6 Million by the end of the analysis period. Growth in the Mechanical segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.0 Million While China is Forecast to Grow at 5.1% CAGR

The Patient-Controlled Analgesic Pumps market in the U.S. is estimated at US$133.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Patient-Controlled Analgesic Pumps Market - Key Trends & Drivers Summarized

Is Pain Management Entering a New Era? The Growing Adoption of Patient-Controlled Analgesic Pumps

Pain management has become a critical focus in modern healthcare, with patient-controlled analgesic (PCA) pumps revolutionizing the way pain relief is administered. These devices empower patients to manage their own pain by delivering controlled doses of analgesic medication, typically opioids or local anesthetics, through intravenous (IV), epidural, or subcutaneous routes. PCA pumps are widely used in post-surgical recovery, cancer pain management, and palliative care, offering personalized pain relief while reducing dependency on nursing staff. Unlike conventional pain management methods, PCA pumps allow for on-demand drug administration within predefined safety limits, minimizing the risk of overmedication and adverse effects. The increasing prevalence of chronic pain conditions, rising surgical volumes, and advancements in pain management protocols are driving the demand for PCA pumps across hospitals, ambulatory surgical centers, and home care settings. With the global opioid crisis raising concerns over prescription drug misuse, PCA technology is being refined to incorporate dose-limiting features, smart drug monitoring, and electronic health record (EHR) integration to ensure safe and effective pain management. As healthcare providers prioritize patient-centered approaches, PCA pumps are emerging as a preferred solution for enhancing pain control and improving patient satisfaction.

How Are Smart Technologies Enhancing PCA Pumps? AI, Wireless Monitoring & Drug Safety Innovations

The integration of smart technologies is transforming PCA pumps, making them safer, more efficient, and better integrated into modern healthcare systems. Advanced PCA pumps now feature wireless connectivity, allowing real-time remote monitoring by healthcare providers to prevent overdose incidents and ensure optimal pain management. AI-powered algorithms are being incorporated into PCA devices to analyze patient responses, detect early signs of opioid-induced respiratory depression, and adjust dosage parameters accordingly. Drug safety innovations such as closed-loop drug delivery systems and barcode medication verification are further enhancing the accuracy of PCA pumps, reducing medication errors, and ensuring compliance with hospital safety protocols. Smart PCA pumps equipped with infusion analytics can track patient usage patterns and provide predictive insights for pain management optimization. Integration with hospital EHRs enables automated documentation of drug administration, improving clinical workflow efficiency and regulatory compliance. The development of non-invasive PCA technologies, including transdermal and intranasal drug delivery systems, is also gaining traction, offering patients needle-free pain relief options. As digital health ecosystems evolve, the convergence of AI, data analytics, and connected devices is reshaping the PCA pump landscape, making pain management safer and more effective.

Where Are PCA Pumps Being Used? Expanding Adoption Across Healthcare Settings

PCA pumps are becoming an essential component of pain management in hospitals, outpatient surgical centers, palliative care, and home healthcare settings. In hospitals, PCA pumps are widely used in post-operative recovery units to manage acute pain following major surgeries such as orthopedic, cardiovascular, and abdominal procedures. Cancer treatment centers are leveraging PCA technology to help patients manage severe cancer-related pain, ensuring continuous relief during chemotherapy and palliative care. Home healthcare providers are increasingly deploying portable PCA pumps to allow patients with chronic pain conditions to receive controlled analgesia in a home setting, reducing hospital visits and improving quality of life. Ambulatory surgical centers are integrating PCA devices into same-day surgical care protocols, enabling efficient pain relief with faster recovery times. Pediatric and geriatric care settings are also adopting PCA pumps, with specialized safety features designed to minimize risks in vulnerable patient populations. Military and trauma care units are exploring the use of PCA technology for battlefield injury management, providing rapid pain relief to injured soldiers in remote locations. As healthcare facilities continue to embrace advanced pain management solutions, the demand for PCA pumps is growing across diverse medical environments.

The Growth in the Patient-Controlled Analgesic Pumps Market Is Driven by Several Factors…

The rising incidence of surgical procedures worldwide is a key driver fueling the growth of the PCA pump market. The increasing prevalence of chronic pain conditions such as cancer, arthritis, and neuropathic pain is boosting demand for advanced pain management solutions. The shift toward patient-centric care models is driving healthcare providers to adopt PCA pumps, enhancing patient autonomy in pain management. Technological advancements, including AI-powered monitoring, wireless connectivity, and automated drug dose control, are making PCA pumps safer and more efficient. The rising concerns over opioid misuse and overdose are leading to the development of smart PCA pumps with enhanced drug safety features. The expansion of home healthcare and remote patient monitoring is creating new opportunities for portable and wearable PCA devices. Regulatory mandates promoting safe pain management practices and opioid stewardship programs are encouraging the adoption of PCA pumps in hospitals and healthcare institutions. The increasing investment in digital health infrastructure is facilitating seamless integration of PCA pumps with hospital electronic health records (EHRs) and clinical decision support systems. Strategic collaborations between medical device manufacturers and pharmaceutical companies are driving innovations in pain relief technologies. As healthcare systems continue to evolve toward precision medicine and data-driven pain management strategies, the patient-controlled analgesic pump market is set for sustained growth, transforming the future of pain therapy.

SCOPE OF STUDY:

The report analyzes the Patient-Controlled Analgesic Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Electronic, Mechanical); Application (Diabetes, Oncology, Gastroenterology, Hematology, Others); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Home Care Settings)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc. (Hospira)
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical (ICU Medical)
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Patient-Controlled Analgesic Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Post-Surgical Pain Management Protocols Accelerates Demand for Patient-Controlled Analgesic Pumps
    • Focus on Personalized Pain Therapy Drives Adoption of PCA Devices
    • Growth in Ambulatory Surgical Centers Expands Use of Portable Analgesic Pumps
    • Integration with Digital Health Records Strengthens Monitoring and Control Capabilities
    • Rising Opioid Safety Concerns Throw the Spotlight on Controlled Drug Delivery Solutions
    • Demand for Non-Invasive Pain Management Spurs Innovation in Pump-Based Therapies
    • Increasing Patient Preference for Self-Managed Pain Relief Drives PCA Device Utilization
    • AI-Enhanced Dosage Monitoring Improves Accuracy and Minimizes Overdose Risk
    • Regulatory Scrutiny on Drug Delivery Devices Spurs Development of Tamper-Resistant Pumps
    • Hospital Efforts to Reduce Nursing Workload Strengthen Use of Automated PCA Systems
    • Expansion of Home Recovery Programs Supports Demand for Compact, User-Friendly Pumps
    • Growth in Pediatric and Geriatric Surgery Volumes Creates Niche PCA Product Demand
    • Clinical Trials Supporting Efficacy Drive Confidence and Market Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient-Controlled Analgesic Pumps Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electronic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electronic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • JAPAN
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CHINA
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • EUROPE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • FRANCE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • GERMANY
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030

IV. COMPETITION